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Abstract
 Purpose—Health-related quality of life (HRQOL) is a critical diabetes outcome, yet 
differences between youth and parent-proxy ratings can make interpretation difficult. This study 
aims to explore potential differences between self- and parent-reports of Pediatric Quality of Life 
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Inventory (PedsQL) scores from youth with type 1 (T1D) or type 2 diabetes (T2D) and to evaluate 
associations between discrepancies, PedsQL scores, and glycemic control (HbA1c).
 Methods—Youth and parents in the SEARCH for Diabetes in Youth Study (T1D: age 5–18, n 
= 3402; T2D: age 8–18, n = 353) completed the PedsQL Generic and Diabetes Modules, and 
youth provided a blood sample to assess HbA1c. Discrepancies (youth minus parent PedsQL 
ratings) were calculated and examined by age and diabetes type, and associations with youth 
PedsQL scores and HbA1c were evaluated.
 Results—Discrepancies existed between youth and parent-proxy reports of generic and 
diabetes PedsQL scores in T1D and T2D (all p values < 0.01). Higher (more favorable) ratings 
were reported by youth except for those 5–7-years old, where parents’ scores were higher. When 
parent-proxy scores were higher, discrepancies were largest when the child reported low PedsQL 
scores. Higher HbA1c was associated with larger discrepancies (youth scores higher) for 
adolescents with T1D.
 Conclusions—Discrepant PedsQL ratings suggest that parents may often underestimate 
youths’ HRQOL except in the youngest children. Although examining both reports is optimal, the 
youth report should be prioritized, particularly for young children with T1D and for adolescents 
with either T1D or T2D.
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 Introduction
Health-related quality of life (HRQOL) is an important construct assessing the impact of a 
medical condition on physical and mental well-being [1]. Research has demonstrated that 
poorer HRQOL is associated with higher HbA1c and greater depressive symptoms in the 
pediatric type 1 diabetes (T1D) and type 2 diabetes (T2D) populations [2, 3]. Clinical 
assessment and discussion of HRQOL is important to comprehensive management of 
diabetes spanning both physical and mental health, and interventions to improve HRQOL 
may promote optimal metabolic and psychosocial outcomes for this population [4].
Administration of the Pediatric Quality of Life Inventory (PedsQL) [5] as a marker of 
HRQOL in health research frequently assesses both the youth and parent perspectives 
(proxy) of the youth’s HRQOL [5, 6]. However, parent-proxy and youth self-reports often 
differ [7]. Little is known about what discrepant scores mean and what they may indicate in 
relation to child health outcomes. This “proxy problem” has been debated in the HRQOL 
literature, [7–9] but no conclusion has been reached on how to handle the apparent 
discrepancies.
Parents of children without chronic illness typically rate their child’s HRQOL better than the 
children themselves; in contrast, parents of children with a variety of chronic health 
conditions (including diabetes) typically rate their child’s HRQOL as worse than children 
themselves [2, 8–10]. However, across studies, the findings tend to be mixed, with 
discrepancies commonly reported in both directions [7, 11–14]. In a cross-sectional analysis 
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of adolescents with chronic conditions and their parents, differences between adolescents 
and parent-proxy scores were found to be statistically significant, although absolute 
differences were small and observed in both directions (i.e., some with youth ratings higher, 
some with parent ratings higher) [7]. Further, analysis of a variety of demographic and 
disease-related factors such as age, gender, and education varied in terms of how they 
associated with the direction of discrepancies across the multiple studies, when reported 
[7,12–14]. In summary, the direction and magnitude of HRQOL discrepancies remain 
unclear, and there are no data on the potential importance of discrepant scores within 
families in relation to clinical outcomes.
Given that many studies, including large-scale clinical trials, collect both the patient and 
parent-proxy reports of HRQOL, understanding discrepancies and their associations with 
glycemic outcomes can inform and clarify the clinical utility and predictive value of these 
tools. We explored these questions with data from the SEARCH for Diabetes in Youth Study 
[15]. Our objectives were to explore the direction and magnitude of discrepancies between 
self- and parent-proxy reports of PedsQL scores in youth with T1D and T2D and to examine 
whether discrepancies were associated with youth-reported PedsQL scores or glycemic 
control. Based on the previous research cited above, we hypothesized that there would be 
discrepancies in both directions and that it would be more common for parental scores to be 
lower than youth scores. Given the minimal evidence in previous literature, our investigation 
of differences between T1D and T2D on discrepancies and demographic and clinical 
predictors of discrepancies was exploratory.
 Methods and materials
 Participants
SEARCH for Diabetes in Youth is a large multicenter study that conducts population-based 
ascertainment of youth with clinically diagnosed, non-gestational diabetes who are <20 at 
the time of diagnosis [16]. SEARCH has enrolled youth newly diagnosed with diabetes from 
2002 through the present. Cases are ascertained from geographically defined populations in 
Ohio, Colorado, South Carolina and Washington, Indian Health Service beneficiaries from 
four American Indian populations, and enrollees in a managed health care plan in California. 
Youths whose diabetes is not secondary to other conditions are invited to a SEARCH study 
visit. After obtaining informed consent and assent, physical measurements were taken, and 
fasting blood samples are collected from metabolically stable children, and questionnaires 
are administered to the children and their accompanying parent. The study protocol was 
approved by the institutional review boards at all of the participating centers.
Youths whose diabetes was incident in 2002 through 2005 or prevalent in 2001 and who 
completed a baseline study visit were eligible for inclusion in these analyses. From this 
group, we selected children with T1D or T2D aged 5 through 18 at the time of their initial 
study visit and for whom we had completed child and the parent-proxy versions of the 
PedsQL questionnaires.
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 Demographic variables—Demographic variables included age at study visit, sex, 
race/ethnicity, highest level of parental education (either parent), and insurance status. 
Insurance was categorized as private, state-funded (Medicaid/Medicare, etc.), other (which 
included student health clinics, military, Indian Health Services), or none. Family 
composition was categorized as two-parent household, one-parent household, or other/
unknown composition.
 Clinical variables—Clinical variables included duration of diabetes at the time the 
survey was completed, insulin regimen, and glycemic control. Insulin regimen was 
categorized as (1) basal-bolus using the insulin pump, (2) basal-bolus with glargine plus 
rapid-acting insulin, (3) multiple daily injections (MDI) with ≥3 injections/day, using 
glargine plus more than/or other than rapid-acting insulin type, (4) MDI with ≥3 injections/
day, using any insulin types excluding basal insulin, or (5) 1–2 injections/day, excluding 
glargine [17]. Detemir and glulisine insulin use was not reported by participants during the 
data collection period.
 Glycemic control—Glycemic control was assessed using blood samples shipped to a 
central laboratory (Northwest Lipid Research Laboratories, Seattle, WA) for analysis. An 
ion exchange unit (Variant II; Bio-Rad Diagnostics, Hercules, CA) quantified the glycated 
hemoglobin (HbA1c) levels.
 Health-related quality of life (HRQOL)—Health-related quality of life (HRQOL) 
was assessed using two modules of the Pediatric Quality of Life Inventory (PedsQL): the 
Generic Core (generic HRQOL) and Diabetes Module (diabetes HRQOL). All youths aged 5 
years and older completed an age-appropriate self-report version of the two modules. For 
children unable to read, items were read out loud. A parent was also invited to complete a 
parent-proxy version of each PedsQL module for all youths who were aged <18 years at the 
time of their visit. Discrepancy scores were calculated as youth total scores minus the 
parent-proxy scores. Individual rating discrepancies were then categorized as “Youth score 
higher” for dyads where the youth scores were higher than parent score or “Parent-proxy 
score higher” for dyads where the parent-proxy scores were higher than the youth score.
 Statistical analysis
Diabetes duration, age, sex, race/ethnicity, insulin regimen, health insurance, highest 
parental education, family income, and family composition were compared by diabetes type. 
Differences were assessed using ANOVA for continuous measures and the Chi-squared tests 
or Fisher’s exact tests for categorical responses. Multivariate linear regression models 
stratified by diabetes type were used to model absolute differences in generic and diabetes-
specific PedsQL scores. Age, gender, race (non-Hispanic White vs. other), type of health 
insurance (private insured vs. other), parental education (less than high school vs. high 
school or more), family composition (one-parent household or other vs. two-parent 
household), and duration of diabetes were included in multivariate linear regression models.
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Paired t tests were used to test for overall differences in parent and child scores. 
Discrepancies in parent-proxy and youth-reported PedsQL scores stratified by the direction 
of the discrepancy, age group, and diabetes type were examined. We explored the average 
differences in discrepancy magnitude across PedsQL tertiles representing the lowest one-
third of youth-reported PedsQL scores, the middle one-third, and the highest one-third. p 
values were assessed using ANOVA to determine whether the discrepancy (for diabetes type 
and direction of discrepancy) differed by tertile.
T tests were used to compare HbA1c values across the two discrepancy direction categories 
(youth score higher vs. parent-proxy score higher), stratified by diabetes type and age group. 
Linear regression models were used to determine the relationship of discrepancy size and 
HbA1c. Models were additionally adjusted for discrepancy direction (youth score higher), 
gender, race, type of health insurance, family composition, number of household members, 
diabetes duration, and age group. We tested for interactions between discrepancy size and 
direction, discrepancy size and age group, and discrepancy direction and age group; no 
interactions were significant and thus were not retained in the presented models. For 
interpretability, a ten-point change in the discrepancy was used. All analyses were performed 




The study included responses from 3755 youth with diabetes of which 3402 had T1D and 
353 had T2D. As expected, there were significant differences in age group, sex, race/
ethnicity, diabetes duration, treatment regimen, health insurance, highest parental education, 
family income, and family composition (all p’s < 0.001) by diabetes type (Table 1). 
Therefore, we conducted the analysis stratified by diabetes type.
 Size and direction of PedsQL rating discrepancies
Mean youth and parent-proxy scores on the generic and diabetes-specific PedsQL are 
displayed in Table 2. Youth with T1D and T2D reported higher scores than parent-proxy 
scores for both generic and diabetes PedsQL modules (all p’s < 0.01). The size and direction 
of the discrepancies, stratified by age, are shown in Table 2. Among youth with T1D 
between the ages of 8–12 and 13–18, it was more common (approximately 2:1) for them to 
rate their generic and their diabetes PedsQL higher than their parents’ proxy scores. Among 
the 5–7-year-olds with T1D, higher parental scores were more common.
For all ages of youth with T2D, it was more common for the youths’ scores to be higher than 
the parents’ scores for both the generic and diabetes PedsQL. All parental and child scores 
significantly differed (p < 0.01 for all comparisons).
 PedsQL discrepancies and demographic variables
Age, sex, race, and insurance were associated with generic PedsQL score discrepancy size in 
youth with T1D. Among youth with T1D, for generic PedsQL, the youngest group (age 5–7) 
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had larger discrepancies compared to adolescents (age 13–18; β = 2.27, p < 0.001). Males 
had larger discrepancies than females (β = −0.83, p = 0.01), and those of non-White race had 
larger discrepancies than White participants (β = 1.21, p < 0.01). Those with private 
insurance had smaller discrepancies than those with public insurance (β = −2.27, p < 0.01), 
and those with two-parent households had smaller discrepancies than those with one-parent 
households (β = 1.34, p < 0.01). For diabetes PedsQL scores in youth with T1D, only 
insurance was associated with discrepancy size, such that those with private insurance had 
smaller discrepancies (β = −1.24, p = 0.01). For youth with T2D, males had larger 
discrepancies than females in generic HRQOL scores (β = 3.79, p = 0.01). No other 
demographic variable was associated with discrepancy size.
 PedsQL discrepancies and glycemic control
Mean HbA1c values for each type of discrepancy (youth score higher vs. parent-proxy score 
higher), stratified by age and diabetes type, are presented in Table 3. For the full sample of 
youth with T1D, HbA1c values were significantly higher among youth whose PedsQL 
scores (both generic and diabetes) were higher than the parent-proxy scores compared to 
those whose parent-proxy ratings were higher. Stratified by age group, this pattern held only 
for youth aged 13–18 (p < 0.01). There were no HbA1c differences by discrepancy direction 
for youth aged 5–7 or 8–12. There were no HbA1c differences by discrepancy direction for 
youth with T2D at any age.
Linear regression models were also used to quantify the relationship between discrepancy 
sizes and HbA1c values (Table 4). Larger discrepancies and the “Youth score higher” group 
were associated with higher HbA1c in T1D after adjusting for sex, insurance, parental 
education, household composition, number of household members, diabetes duration, and 
age group. A ten-unit increase in generic and diabetes-specific PedsQL discrepancy size was 
associated with a 0.07 % and 0.08 % increase, respectively, in HbA1c. Youths who scored 
higher than their parents were associated with an 0.11 (for generic PedsQL) and 0.12 (for 
diabetes PedsQL) percent increase in HbA1c.
 Discussion
This study investigated the magnitude and direction of discrepancies between youth and 
parent-proxy reports of both generic and disease-specific PedsQL scores in a large, national 
sample of youth with T1D and T2D. We found that the majority of youth with T1D and T2D 
reported higher generic and diabetes-specific PedsQL scores than their parent reported. The 
only exception was in the T1D 5–7-year-old age group, where the majority of parents rated 
their child’s generic and diabetes-specific HRQOL higher than the youth.
Previous studies of the “proxy problem” have not been conducted in such large samples nor 
have they been stratified by age or diabetes type. Our report suggests that parents may 
underestimate youths’ PedsQL scores, except in the youngest children with T1D. Also of 
note in the 5–7-year-old T1D group was the finding that for parents rating youth PedsQL 
higher than the child (55 % of all parents for generic and 53 % for diabetes-specific), the 
magnitude of discrepancy was also the largest. Clearly there is a disconnection between 
parents’ and youths’ perceptions of youth HRQOL in this young age group. Given that 
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parents are doing much of the diabetes care at this stage, many may underestimate the effect 
diabetes has on their young child. Parents of young children with diabetes may have 
difficulty distinguishing between normative and diabetes-related behavior, so it may be 
difficult to accurately assess their child’s overall well-being [18].
When we examined discrepancies of PedsQL reports in relation to youths’ HbA1c levels at 
the time of the study visit, we found that among adolescents 13–18-years old with T1D, 
HbA1c values were higher when the youth reported higher PedsQL scores than their parent 
reported, for both the generic and diabetes-specific PedsQL modules. Further, larger 
discrepancies were associated with worse glycemic control. Given adolescents are more 
likely to have worsening treatment adherence and poor glycemic control [19], it is possible 
that parental perceptions of adolescent HRQOL may take adherence or glycemic control into 
consideration, thus rating HRQOL lower when HbA1c is poor; however, teens’ own 
perceptions of HRQOL may not be related to HbA1c. These results may also reflect 
differences between parent and youth perspectives on HRQOL that encompass broader 
family issues that were not measured in this study, such as family conflict or poor 
communication in the home, as both have been associated with HRQOL and HbA1c [15–
17]. This finding was only observed among youth with T1D. There were no associations 
between discrepancies and HbA1c among the youth with T2D.
We found consistent differences between T1D and T2D groups in relation to discrepancy 
size and demographic and clinical correlates of discrepancies. The smaller HRQOL 
discrepancies in T1D may reflect a relatively higher level of involvement in diabetes 
management among caregivers of youth with T1D; however, this is speculative as we are not 
aware of research comparing parent involvement in T1D versus T2D. Additionally, larger 
discrepancies were associated with demographic variables such as race and insurance status 
for T1D. More research is needed on the relationships between parental involvement, 
reported discrepancies, and demographic variables, particularly ones that reflect socio-
economic status that we found significant in the T1D sample as they may be another 
indicator of the negative effects of health disparities. The lack of association between 
demographic variables and HRQOL discrepancies in T2D may be related to less variability 
(i.e., lower SES overall, more racial/ethnic minorities) in the T2D sample.
Limitations of this study included the cross-sectional design, which prohibits our ability to 
establish causality, particularly in the analyses with HbA1c in which the directionality of the 
associations we found remains unclear. Further, our study was not able to provide clarity on 
the reasons for the differences between the discrepant reports. Future research would benefit 
in understanding more about the nature of these reasons and how to reduce discrepancies. 
Lastly, we were unable to answer the question of whose HRQOL is more important to 
collect, as that becomes more of a philosophical versus empirical question undoubtedly 
influenced by many factors beyond what we have collected here.
In summary, our study investigated the difference between child and parent-proxy scores on 
the generic and diabetes-specific PedsQL modules. Despite the limitations listed above, we 
found that indeed discrepancies not only exist, but they relate to glycemic outcomes among 
adolescents with T1D. Thus, in the context of clinical care it is important to consider 
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discrepancies in HRQOL reports as much as possible, as large discrepancies, particularly 
when the parents report higher scores than their child, can indicate a worrisome lack of 
correspondence between the parent’s and the adolescent’s perspectives. If providers note 
large discrepancies, it may be beneficial to dedicate more time to discussing HRQOL issues 
with families. However, more research is needed to determine whether HRQOL 
interventions [19] for families with larger versus smaller discrepancies are impactful.
Taken together, our findings support prior recommendations [17, 18] to use the youth report 
(when available) in conjunction with the parent-proxy report when making determinations 
on youth HRQOL. However, when youth and parent-proxy scores are highly discrepant, they 
should be considered individually and not be averaged together or otherwise aggregated. 
This may be particularly important in adolescence, given the large discrepancies found in 
T2D and the association of larger discrepancies with HbA1c in adolescents with T1D. 
Although examining both reports is optimal, if it is unrealistic to collect both, the youth 
report should be prioritized.
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Table 1
Demographic and clinical information characteristics of the 3755 participants in the study sample, by diabetes 
type: the SEARCH for diabetes in youth study
Characteristic T1D, N = 3402 T2D, N = 353*
N % or M (SD) N % or M (SD)
Age at study visit, years
 5–7 581 17.1 0 –
 8–11 1438 42.3 68 19.3
 13–18 1383 40.7 285 80.7
 Age (mean, SD years) 11.9 (3.4) 14.9 (2.0)
Duration (months) 38.3 (39.6) 17.6 (16.5)
Gender (female) 1702 50.0 222 62.9
Insulin regimen
 Pump 533 15.9 1 0.7
 Long + short/rapid insulin, three or more times a day 833 24.8 16 11.6
 Long + any other combination, two or more times a day 317 9.4 5 3.6
 Any combination of insulins excluding long, three or more times/day 516 15.4 27 19.6
 Any insulin(s) taken 1x/day, or any insulin combination excluding long 2x/day 1158 34.5 89 64.5
 Not on insulin 44 1.3 211 60.5
Race/ethnicity
 Black 319 9.4 124 35.1
 Hispanic 382 11.3 91 25.8
 Other 103 3.0 55 15.6
 Non-hispanic White 2598 76.4 83 23.5
Type of health insurance
 None 32 0.9 12 3.4
 Other 59 1.7 15 4.3
 Medicaid 577 17.0 134 38.4
 Private 2719 80.3 188 53.9
Highest level of education of either parent
 Bachelors degree or more 1575 46.5 53 15.1
 Some college through associate degree 1163 34.3 126 35.8
 High school graduate 504 14.9 112 31.8
 Less than high school graduate 145 4.3 61 17.3
Family composition
 One-parent household 939 27.7 169 48.0
 Two-parents/one household 2350 69.3 160 45.5
 Other 100 3.0 23 6.5
Income
 $25–49 K 747 22.1 93 26.4
 $50–74 K 697 20.6 38 10.8
 $75 K+ 1336 39.5 33 9.4
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Characteristic T1D, N = 3402 T2D, N = 353*
N % or M (SD) N % or M (SD)
 < $25 K 432 12.8 151 42.8
 Don’t know or refused 173 5.1 38 10.76
*
All p’s < 0.001 for comparison by diabetes type
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Table 2
Overall youth and parent scores, and direction and magnitude of discrepancy scores (absolute value), stratified 
by age, for generic and diabetes-specific PedsQL Modules
Age
group
PedsQL score: M ± SD Youth score higher Parent-proxy score higher
Youth Parent-proxy Percent of
age group
Discrepancy




size, M ± SD
Type 1 diabetesa,b
 Generic All 80.3 ± 13.2 78.0 ± 14.08
5–7 71.7 ± 14.6 78.4 ± 12.7 45 10.0 ± 8.6 55 15.5 ± 11.9
8–12 81.7 ± 12.7 78.6 ± 13.6 62 11.4 ± 9.7 38 10.0 ± 8.4
13–18 82.5 ± 11.6 77.1 ± 15.0 67 12.4 ± 11.0 33 9.0 ± 6.9
 Diabetes All 74.7 ± 13.5 70.4 ± 13.1
5–7 68.3 ± 14.3 71.1 ± 11.9 47 10.6 ± 9.5 53 14.5 ± 11.6
8–12 77.1 ± 13.1 71.5 ± 12.5 68 13.2 ± 9.8 32 10.3 ± 8.9
13–18 74.9 ± 12.7 69.0 ± 14.1 68 13.2 ± 10.0 32 9.8 ± 7.8
Type 2 diabetesa
 Generic All 75.0 ± 15.4 67.4 ± 17.4
8–12 73.1 ± 19.3 66.2 ± 17.7 71 15.5 ± 12.0 29 13.4 ± 15.3
13–18 75.5 ± 14.4 67.7 ± 17.3 65 17.8 ± 12.9 35 10.7 ± 8.7
 Diabetes All 71.5 ± 15.6 68.0 ± 15.9
8–12 69.6 ± 19.1 68.9 ± 15.3 62 12.3 ± 9.9 38 18.0 ± 15.0
13–18 72.0 ± 14.7 67.8 ± 16.0 61 14.3 ± 11.3 39 11.4 ± 8.4
a
All p values < 0.01 for comparisons of youth versus parent-proxy scores
b
All p values < 0.001 for comparisons between age groups per type of discrepancy
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Table 3
T-tests comparing HbA1c values by discrepancy direction, stratified by diabetes type and age group
Generic PedsQL Diabetes PedsQL










 All Ages 8.2 ± 1.7 8.0 ± 1.4 <0.0001 0.14 8.2 ± 1.6 8.0 ± 1.5 0.00 0.13
 5–7 years 7.9 ± 1.3 7.9 ± 1.1 0.82 0.02 7.9 ± 1.2 7.9 ± 1.1 0.81 0.02
 8–12 years 8.0 ± 1.4 8.0 ± 1.3 0.44 0.04 8.0 ± 1.4 7.9 ± 1.4 0.07 0.11
 13–18 years 8.4 ± 1.9 8.1 ± 1.7 0.00 0.18 8.4 ± 1.9 8.2 ± 1.8 0.04 0.12
Type 2 diabetes
 All Ages 7.8 ± 2.3 7.3 ± 2.2 0.06 0.22 7.7 ± 2.3 7.5 ± 2.1 0.29 0.12
 8–12 years 6.8 ± 1.6 7.5 ± 2.2 0.17 0.37 7.1 ± 2.1 7.5 ± 2.0 0.41 0.21
 13–18 years 7.4 ± 2.3 7.8 ± 2.3 0.12 0.20 7.5 ± 2.1 7.8 ± 2.4 0.42 0.10
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Table 4
Linear regression models of generic and diabetes HRQOL predicting HbA1C, stratified by diabetes type
Parameter HbA1c
Version Beta SE p value Version Beta SE p value
Type 1 diabetes
 PedsQL: Absolute difference (youth–parent),
  10-point difference
Generic 0.07 0.03 0.01 Diabetes-Specific 0.08 0.03 0.00
 Youth PedsQL score higher 0.11 0.05 0.04 0.12 0.06 0.03
 Female sex 0.14 0.05 0.01 0.14 0.05 0.01
 Non-White race 0.43 0.07 <.0001 0.43 0.07 <.0001
 Private insurance −0.28 0.07 0.00 −0.28 0.07 <.0001
 Parental education > HS −0.22 0.07 0.00 −0.23 0.07 0.00
 Not living in a two-parent household 0.34 0.06 <.0001 0.35 0.06 <.0001
 Number of household members 0.04 0.02 0.08 0.04 0.02 0.08
 Diabetes duration (months) 0.01 0.00 <.0001 0.01 0.00 <.0001
Age group
  Ages 5–7 −0.1 0.08 0.21 −0.1 0.08 0.2
  Ages 8–12 −0.1 0.06 0.09 −0.11 0.06 0.06
  Ages 13–18 Ref Ref
Type 2 diabetes
 PedsQL: Absolute Difference (youth–parent),
  10-point difference
Generic 0.1 0.1 0.32 Diabetes-Specific 0.04 0.11 0.72
 Youth PedsQL score higher 0.52 0.26 0.04 0.28 0.24 0.25
 Female sex 0.22 0.25 0.38 0.18 0.25 0.48
 Non-White race 0.58 0.29 0.04 0.64 0.29 0.03
 Private insurance 0.1 0.25 0.69 0.13 0.25 0.6
 Parental education > HS −0.03 0.24 0.9 −0.09 0.24 0.71
 Not living in a two-parent household −0.75 0.25 0.00 −0.77 0.26 0.00
 Number of household members 0.06 0.07 0.44 0.05 0.08 0.54
 Diabetes duration (months) 0.04 0.01 <.0001 0.04 0.01 <.0001
Age group
  Ages 8–12 −0.08 0.3 0.79 −0.07 0.3 0.81
  Ages 13–18 Ref Ref
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